title: Fondaparinux-related thrombocytopenia in a patient with former HIT. Response to Rota et al. (Thromb Haemost 2008; 99: 779-781).
authors.forename: Marc
authors.initials: M
authors.lastname: Schindewolf
authors.forename: Edelgard
authors.initials: E
authors.lastname: Lindhoff-Last
mesh_terms: D000906:Antibodies / Q000097:blood; D000925:Anticoagulants / Q000009:adverse effects* / Q000276:immunology; D000077425:Fondaparinux; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D010976:Platelet Count; D010978:Platelet Factor 4 / Q000276:immunology; D011134:Polysaccharides / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced* / Q000276:immunology; D020246:Venous Thrombosis / Q000517:prevention & control*
chemical_list: D000906:Antibodies; D000925:Anticoagulants; D011134:Polysaccharides; D010978:Platelet Factor 4; D006493:Heparin; D000077425:Fondaparinux